Derivatives of N- [phenyl(pyrrolidine-2-yl)methyl]benzami de and N- [(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics

Details for Australian Patent Application No. 2004281218 (hide)

Owner Sanofi-Aventis

Inventors Estenne-Bouhtou, Genevieve; Medaisko, Florence; Dargazanli, Gihad; Rakotoarisoa, Nathalie

Agent Davies Collison Cave

Pub. Number AU-B-2004281218

PCT Pub. Number WO2005/037785

Priority 0312143 17.10.03 FR

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 10 February 2011

International Classifications

C07D 223/04 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/037785 Priority application(s): WO2005/037785

10 February 2011 Application Accepted

  Published as AU-B-2004281218

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281220-Novel IgG3 antibodies for stimulating phagocytosis

2004281217-Use of tricyclic compounds as glycine transport inhibitors